AXIM BIOTECHNOLOGIES, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $0.37 per share for the 9-month period ending 2022-09-30, per its 10-Q/A filed 2022-11-15.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2022-11-15
- AXIM BIOTECHNOLOGIES, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2022-03-31 was $0.37.
- AXIM BIOTECHNOLOGIES, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2020 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2019 was $0.00.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2022-09-30 | $0.37 10-Q/A · filed 2022-11-15 | |||
| 2022-06-30 | $0.37 10-Q · filed 2022-08-16 | |||
| 2022-03-31 | $0.37 10-Q · filed 2022-05-23 | |||
| 2021-12-31 | $0.35 10-Q/A · filed 2022-11-15 | |||
| 2020-12-31 | $0.00 10-K/A · filed 2022-04-19 | |||
| 2019-12-31 | $0.00 10-K/A · filed 2021-04-26 |